Extensive-stage Small Cell Lung Cancer (ES-SCLC) Clinical Trials in Detroit, Michigan
2 recruitingDetroit, Michigan
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Extensive-stage Small Cell Lung Cancer (ES-SCLC)Small Cell Lung Cancer ( SCLC )
Bindu R Potugari35 enrolled1 locationNCT07339059
Recruiting
Phase 1
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Breast CancerColorectal, CancerOvarian Cancer+6 more
IDEAYA Biosciences216 enrolled27 locationsNCT05787587